The World Health Organization now recognizes obesity as a chronic disease and recommends GLP-1 weight loss drugs such as Ozempic and Mounjaro as part of long-term treatment. Until now, the … Continue reading WHO’s Obesity Guidelines: Benefits, Risks, and Long-Term Use of GLP-1 Drugs